Biogen (BIIB) Assets (2009 - 2026)

Biogen has reported Assets for 18 years, with the latest figure at $32.1 billion in Q2 2026.

• On a quarterly basis, Assets rose 13.26% year-over-year to $32.1 billion in Q2 2026; TTM through Jun 2026 was $32.1 billion, a 13.26% increase from a year earlier, with the FY2025 full-year figure at $29.4 billion, up 4.96% from the prior year.
• Assets was $32.1 billion for Q2 2026 at Biogen, up from $29.5 billion in the prior quarter.
• The five-year high for Assets was $32.1 billion in Q2 2026, with the low at $23.6 billion in Q1 2022.
• Average Assets over 5 years is $27.2 billion, with a median of $27.4 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Assets decreased 1.01% in 2022, then climbed 13.43% in 2023.
• Over 5 years, Assets stood at $24.6 billion in 2022, then grew by 9.33% to $26.8 billion in 2023, then gained by 4.49% to $28.0 billion in 2024, then gained by 4.96% to $29.4 billion in 2025, then gained by 8.99% to $32.1 billion in 2026.
• The last three Assets figures came in at $32.1 billion (Q2 2026), $29.5 billion (Q1 2026), and $29.4 billion (Q4 2025), per Business Quant data.